BAUSCH HEALTH COS INC (BHC) Fundamental Analysis & Valuation

NYSE:BHC • CA0717341071

Current stock price

5.605 USD
+0.22 (+3.99%)
Last:

This BHC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. BHC Profitability Analysis

1.1 Basic Checks

  • BHC had positive earnings in the past year.
  • BHC had a positive operating cash flow in the past year.
  • BHC had negative earnings in 4 of the past 5 years.
  • Of the past 5 years BHC 4 years had a positive operating cash flow.
BHC Yearly Net Income VS EBIT VS OCF VS FCFBHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B -2B -4B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 0.60%, BHC is in the better half of the industry, outperforming 79.69% of the companies in the same industry.
  • With an excellent Return On Invested Capital value of 7.78%, BHC belongs to the best of the industry, outperforming 85.94% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for BHC is significantly below the industry average of 13.06%.
  • The 3 year average ROIC (6.89%) for BHC is below the current ROIC(7.78%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 0.6%
ROE N/A
ROIC 7.78%
ROA(3y)-0.58%
ROA(5y)-1.17%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)6.89%
ROIC(5y)6.18%
BHC Yearly ROA, ROE, ROICBHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200 400 600 800

1.3 Margins

  • BHC has a better Profit Margin (1.53%) than 79.69% of its industry peers.
  • BHC has a Operating Margin of 21.28%. This is amongst the best in the industry. BHC outperforms 88.02% of its industry peers.
  • BHC's Operating Margin has improved in the last couple of years.
  • Looking at the Gross Margin, with a value of 70.65%, BHC is in the better half of the industry, outperforming 77.08% of the companies in the same industry.
  • In the last couple of years the Gross Margin of BHC has remained more or less at the same level.
Industry RankSector Rank
OM 21.28%
PM (TTM) 1.53%
GM 70.65%
OM growth 3Y7.55%
OM growth 5Y5.41%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.12%
GM growth 5Y-0.37%
BHC Yearly Profit, Operating, Gross MarginsBHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. BHC Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), BHC is creating some value.
  • Compared to 1 year ago, BHC has more shares outstanding
  • The number of shares outstanding for BHC has been increased compared to 5 years ago.
  • The debt/assets ratio for BHC has been reduced compared to a year ago.
BHC Yearly Shares OutstandingBHC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
BHC Yearly Total Debt VS Total AssetsBHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

2.2 Solvency

  • Based on the Altman-Z score of 0.28, we must say that BHC is in the distress zone and has some risk of bankruptcy.
  • BHC has a Altman-Z score of 0.28. This is comparable to the rest of the industry: BHC outperforms 48.96% of its industry peers.
  • BHC has a debt to FCF ratio of 21.00. This is a negative value and a sign of low solvency as BHC would need 21.00 years to pay back of all of its debts.
  • BHC has a better Debt to FCF ratio (21.00) than 76.04% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 21
Altman-Z 0.28
ROIC/WACC1.2
WACC6.49%
BHC Yearly LT Debt VS Equity VS FCFBHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10B 20B

2.3 Liquidity

  • A Current Ratio of 1.47 indicates that BHC should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.47, BHC is doing worse than 74.48% of the companies in the same industry.
  • BHC has a Quick Ratio of 1.08. This is a normal value and indicates that BHC is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.08, BHC is doing worse than 77.08% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.47
Quick Ratio 1.08
BHC Yearly Current Assets VS Current LiabilitesBHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. BHC Growth Analysis

3.1 Past

  • BHC shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by 0.00%.
  • The Earnings Per Share has been decreasing by -1.13% on average over the past years.
  • Looking at the last year, BHC shows a small growth in Revenue. The Revenue has grown by 6.66% in the last year.
  • BHC shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.04% yearly.
EPS 1Y (TTM)0%
EPS 3Y6.97%
EPS 5Y-1.13%
EPS Q2Q%-4.35%
Revenue 1Y (TTM)6.66%
Revenue growth 3Y8.11%
Revenue growth 5Y5.04%
Sales Q2Q%9.26%

3.2 Future

  • BHC is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -1.34% yearly.
  • Based on estimates for the next years, BHC will show a decrease in Revenue. The Revenue will decrease by -0.94% on average per year.
EPS Next Y15.65%
EPS Next 2Y3.9%
EPS Next 3Y-5.25%
EPS Next 5Y-1.34%
Revenue Next Year4.48%
Revenue Next 2Y2.16%
Revenue Next 3Y-2.16%
Revenue Next 5Y-0.94%

3.3 Evolution

  • The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BHC Yearly Revenue VS EstimatesBHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B 8B 10B
BHC Yearly EPS VS EstimatesBHC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

9

4. BHC Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 1.49, the valuation of BHC can be described as very cheap.
  • BHC's Price/Earnings ratio is rather cheap when compared to the industry. BHC is cheaper than 99.48% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of BHC to the average of the S&P500 Index (26.91), we can say BHC is valued rather cheaply.
  • Based on the Price/Forward Earnings ratio of 1.29, the valuation of BHC can be described as very cheap.
  • 98.96% of the companies in the same industry are more expensive than BHC, based on the Price/Forward Earnings ratio.
  • BHC's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.68.
Industry RankSector Rank
PE 1.49
Fwd PE 1.29
BHC Price Earnings VS Forward Price EarningsBHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, BHC is valued cheaply inside the industry as 95.31% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, BHC is valued cheaper than 99.48% of the companies in the same industry.
Industry RankSector Rank
P/FCF 2.09
EV/EBITDA 6.35
BHC Per share dataBHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 -40

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of BHC may justify a higher PE ratio.
  • A cheap valuation may be justified as BHC's earnings are expected to decrease with -5.25% in the coming years.
PEG (NY)0.1
PEG (5Y)N/A
EPS Next 2Y3.9%
EPS Next 3Y-5.25%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BHC Dividend Analysis

5.1 Amount

  • BHC does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BHC Fundamentals: All Metrics, Ratios and Statistics

BAUSCH HEALTH COS INC

NYSE:BHC (4/10/2026, 12:48:58 PM)

5.605

+0.22 (+3.99%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-20
Earnings (Next)04-29
Inst Owners44.72%
Inst Owner Change0%
Ins Owners11.42%
Ins Owner Change10.2%
Market Cap2.08B
Revenue(TTM)10.27B
Net Income(TTM)157.00M
Analysts48.89
Price Target7.43 (32.56%)
Short Float %2.18%
Short Ratio2.77
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-5.64%
Min EPS beat(2)-13.87%
Max EPS beat(2)2.59%
EPS beat(4)1
Avg EPS beat(4)-10.87%
Min EPS beat(4)-25.13%
Max EPS beat(4)2.59%
EPS beat(8)3
Avg EPS beat(8)-7.33%
EPS beat(12)6
Avg EPS beat(12)-4.52%
EPS beat(16)7
Avg EPS beat(16)-7.67%
Revenue beat(2)2
Avg Revenue beat(2)1.43%
Min Revenue beat(2)0.64%
Max Revenue beat(2)2.23%
Revenue beat(4)3
Avg Revenue beat(4)0.41%
Min Revenue beat(4)-1.57%
Max Revenue beat(4)2.23%
Revenue beat(8)6
Avg Revenue beat(8)0.66%
Revenue beat(12)9
Avg Revenue beat(12)1.15%
Revenue beat(16)10
Avg Revenue beat(16)0.16%
PT rev (1m)0%
PT rev (3m)0.47%
EPS NQ rev (1m)-6.59%
EPS NQ rev (3m)-6.38%
EPS NY rev (1m)0%
EPS NY rev (3m)1.71%
Revenue NQ rev (1m)-0.78%
Revenue NQ rev (3m)-1.02%
Revenue NY rev (1m)0.12%
Revenue NY rev (3m)0.35%
Valuation
Industry RankSector Rank
PE 1.49
Fwd PE 1.29
P/S 0.2
P/FCF 2.09
P/OCF 1.48
P/B N/A
P/tB N/A
EV/EBITDA 6.35
EPS(TTM)3.77
EY67.26%
EPS(NY)4.36
Fwd EY77.79%
FCF(TTM)2.68
FCFY47.81%
OCF(TTM)3.78
OCFY67.41%
SpS27.7
BVpS-1.5
TBVpS-44.44
PEG (NY)0.1
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 0.6%
ROE N/A
ROCE 9.85%
ROIC 7.78%
ROICexc 8.27%
ROICexgc 34.78%
OM 21.28%
PM (TTM) 1.53%
GM 70.65%
FCFM 9.67%
ROA(3y)-0.58%
ROA(5y)-1.17%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)6.89%
ROIC(5y)6.18%
ROICexc(3y)7.29%
ROICexc(5y)6.47%
ROICexgc(3y)46.04%
ROICexgc(5y)39.55%
ROCE(3y)8.72%
ROCE(5y)7.82%
ROICexgc growth 3Y6.69%
ROICexgc growth 5Y7.05%
ROICexc growth 3Y16.83%
ROICexc growth 5Y15.41%
OM growth 3Y7.55%
OM growth 5Y5.41%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.12%
GM growth 5Y-0.37%
F-Score6
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 21
Debt/EBITDA 6.08
Cap/Depr 33.69%
Cap/Sales 3.96%
Interest Coverage 1.42
Cash Conversion 41.26%
Profit Quality 632.48%
Current Ratio 1.47
Quick Ratio 1.08
Altman-Z 0.28
F-Score6
WACC6.49%
ROIC/WACC1.2
Cap/Depr(3y)27.35%
Cap/Depr(5y)23.9%
Cap/Sales(3y)3.53%
Cap/Sales(5y)3.45%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3Y6.97%
EPS 5Y-1.13%
EPS Q2Q%-4.35%
EPS Next Y15.65%
EPS Next 2Y3.9%
EPS Next 3Y-5.25%
EPS Next 5Y-1.34%
Revenue 1Y (TTM)6.66%
Revenue growth 3Y8.11%
Revenue growth 5Y5.04%
Sales Q2Q%9.26%
Revenue Next Year4.48%
Revenue Next 2Y2.16%
Revenue Next 3Y-2.16%
Revenue Next 5Y-0.94%
EBIT growth 1Y17.85%
EBIT growth 3Y16.27%
EBIT growth 5Y10.72%
EBIT Next Year33.3%
EBIT Next 3Y-2.01%
EBIT Next 5Y1.11%
FCF growth 1Y-21%
FCF growth 3YN/A
FCF growth 5Y4.37%
OCF growth 1Y-12.34%
OCF growth 3YN/A
OCF growth 5Y4.73%

BAUSCH HEALTH COS INC / BHC Fundamental Analysis FAQ

What is the ChartMill fundamental rating of BAUSCH HEALTH COS INC (BHC) stock?

ChartMill assigns a fundamental rating of 4 / 10 to BHC.


What is the valuation status of BAUSCH HEALTH COS INC (BHC) stock?

ChartMill assigns a valuation rating of 9 / 10 to BAUSCH HEALTH COS INC (BHC). This can be considered as Undervalued.


What is the profitability of BHC stock?

BAUSCH HEALTH COS INC (BHC) has a profitability rating of 6 / 10.


How financially healthy is BAUSCH HEALTH COS INC?

The financial health rating of BAUSCH HEALTH COS INC (BHC) is 3 / 10.


What is the earnings growth outlook for BAUSCH HEALTH COS INC?

The Earnings per Share (EPS) of BAUSCH HEALTH COS INC (BHC) is expected to grow by 15.65% in the next year.